Lipocine
LPCN
LPCN
44 hedge funds and large institutions have $102M invested in Lipocine in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% more funds holding
Funds holding: 39 → 44 (+5)
0.09% more ownership
Funds ownership: 0.71% → 0.79% (+0.09%)
Holders
44
Holding in Top 10
–
Calls
$1.77M
Puts
$195K
Top Buyers
| 1 | +$85.8M | |
| 2 | +$901K | |
| 3 | +$771K | |
| 4 |
Two Sigma Investments
New York
|
+$353K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$242K |
Top Sellers
| 1 | -$437K | |
| 2 | -$250K | |
| 3 | -$185K | |
| 4 |
BlackRock
New York
|
-$40.9K |
| 5 |
HF
HRT Financial
New York
|
-$23K |